JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇧🇪🏛️

Regulatory Hierarchy

Belgian regulatory structure for medicinal cannabis — FAMHP and magistral preparation

Regulatory Structure Verified 2026-04-20

Workflow steps

  1. FAMHP — Federal Agency for Medicines and Health Products (AFMPS/FAGG)
    Primary regulator for all medicines including cannabis. Issues import authorizations, EU-GMP certificates, and manages the magistral preparation framework. Belgium is EEA — FAMHP is a major EU-GMP issuing authority and significant pharma manufacturing hub.
    • Per-shipment import authorizations
    • EU-GMP certification (EEA authority)
    • Wholesale dealer authorizations
    • Magistral preparation oversight
    • Pharmacovigilance
  2. Ministry of Health — Policy oversight
    Sets national medicinal cannabis policy. Oversees FAMHP. Belgium permits cannabis access via authorized products (Sativex) and magistral preparation — a significant access pathway.
    • National cannabis access policy
    • Oversight of FAMHP
    • Loi coordonnée sur les médicaments framework
  3. Magistral Preparation Pharmacies — Compounding pharmacists
    A SIGNIFICANT access pathway in Belgium. Pharmacists compound preparations from imported cannabis flower or extract under FAMHP-approved magistral preparation formulas. This is distinct from standard dispensing — the pharmacist is the manufacturer.
    • Licensed pharmacist with magistral preparation authorization
    • FAMHP-approved preparation formula
    • Cannabis sourced from FAMHP-authorized imports only
    • GDP and magistral preparation GMP compliance
  4. Patients — End recipients
    Access via standard prescription (Sativex) or magistral preparation. Named-patient authorization (ATU-equivalent) also available. Belgium's magistral preparation pathway provides broader access than many EU countries.
Import Authorization